Oligonucleotide Separation Using Strong-Salt Chaotrope Chromatography

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The challenge of separating desired oligomeric compounds from contaminants, such as deamination, de-phosphorothioated, and de-adenylated products, in oligonucleotide mixtures remains unsolved, hindering the development of effective oligonucleotide-based therapeutics.

Innovation Solution

A method involving chromatography using a mobile phase comprising a strong salt and a chaotrope is employed to separate oligomeric compounds from contaminants, utilizing a column with a stationary phase like surface-modified polystyrene or silica, achieving effective separation of structurally similar compounds.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional chromatography methods are used to separate oligomeric compounds from contaminants, then the separation process is simple, but the separation efficiency and purity are insufficient

Engineering Contradiction:
Improveseparation purityVSAvoidchromatography system complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent modifies the mobile phase composition parameters by incorporating chaotropic agents (guanidinium salts, ammonium salts) and adjusting salt concentrations to achieve superior separation of oligomeric compounds from contaminants. This parameter optimization enables effective separation without requiring complex chromatography systems, resolving the contradiction between separation purity and system complexity.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If multi-step chemical synthesis is used to produce oligomeric compounds, then the compound can be synthesized with desired properties, but unwanted contaminants are introduced

Engineering Contradiction:
Improvesynthesis feasibilityVSAvoidproduct purity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent extracts and removes unwanted contaminants from the synthesis mixture using selective chromatography methods. By developing specific mobile phase compositions with chaotropic agents, the method selectively extracts contaminants while preserving the desired oligomeric compounds, thus maintaining synthesis feasibility while improving product purity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical parameters of the mobile phase by introducing chaotropic agents and optimizing salt concentrations to enable selective separation. This allows the synthesis process to remain straightforward while achieving high product purity through parameter-optimized chromatography.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If standard mobile phases are used in chromatography, then the system is simple to operate, but structurally similar oligomeric compounds cannot be effectively separated

Engineering Contradiction:
Improveseparation resolutionVSAvoidchromatography operation simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent modifies mobile phase parameters by incorporating chaotropic agents (guanidinium chloride, ammonium acetate) and adjusting ionic strength to enhance the separation resolution of structurally similar oligomeric compounds. These parameter changes achieve effective separation while maintaining operational simplicity, as the modified mobile phases can be implemented using standard chromatography equipment.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method significantly improves the separation of oligomeric compounds from contaminants, allowing for the purification of therapeutic compounds with high purity and efficiency.

Implementation Method 1

chromatography using a mobile phase comprising a strong salt and a chaotrope

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS20250215417A1Methods for Separating Certain Oligonucleotide Compounds
Publication Date: 2025.07.03 IONIS PHARMACEUTICALS INC
  • US20250215417A1 patent drawing
  • US20250215417A1 patent drawing
  • US20250215417A1 patent drawing

AI summary

Provided are methods for reducing the amount of a contaminant in a sample containing an oligomeric compound. The method may comprise chromatography using a mobile phase comprising a strong salt and a chaotrope. Also provided are oligomeric compounds prepared by the method.